Cybin To Acquire Small Pharma Inc.; Small Pharma Shareholders Will Receive 0.2409 Common Shares In The Capital Of Cybin; Exchange Ratio Implies Consideration Of ~$0.10 Per Small Pharma Share
- All-share transaction creates international clinical-stage leader in novel psychedelic therapeutics -
- Two proprietary, advanced clinical programs in development for depression and anxiety disorders with demonstrated
